BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3087346)

  • 21. Urinary excretion of sulphated N-acetylhexosamines in patients with various mucopolysaccharidoses.
    Hopwood JJ; Elliott H
    Biochem J; 1985 Aug; 229(3):579-86. PubMed ID: 3931626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase.
    O'Brien JF; Cantz M; Spranger J
    Biochem Biophys Res Commun; 1974 Oct; 60(3):1170-7. PubMed ID: 4215420
    [No Abstract]   [Full Text] [Related]  

  • 23. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.
    Jezyk PF; Haskins ME; Patterson DF; Mellman WJ; Greenstein M
    Science; 1977 Nov; 198(4319):834-6. PubMed ID: 144321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome.
    Matalon R; Arbogast B; Dorfman A
    Biochem Biophys Res Commun; 1974 Dec; 61(4):1450-7. PubMed ID: 4218107
    [No Abstract]   [Full Text] [Related]  

  • 25. Report of a mucopolysaccharidosis occurring in Australian aborigines.
    Taylor HR; Hollows FC; Hopwood JJ; Robertson EF
    J Med Genet; 1978 Dec; 15(6):455-61. PubMed ID: 106124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
    Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
    Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Prenatal diagnosis of Maroteaux-Lamy syndrome.
    Kleijer WJ; Wolffers GM; Hoogeveen A; Niermeijer MF
    Lancet; 1976 Jul; 2(7975):50. PubMed ID: 59120
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative activity of sulphatases in human liver on two synthetic substrates.
    Hultberg B
    Clin Chim Acta; 1977 Nov; 80(3):423-9. PubMed ID: 21050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1982 Aug; 123(3):241-50. PubMed ID: 6811162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer.
    Peters C; Rommerskirch W; Modaressi S; von Figura K
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):499-504. PubMed ID: 1904721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of the mucopolysaccharidoses using cultured skin fibroblasts and amniotic fluid cells.
    Butterworth J
    J Inherit Metab Dis; 1978; 1(1):25-8. PubMed ID: 117232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase.
    Hopwood JJ; Muller VJ
    Carbohydr Res; 1983 Oct; 122(2):227-39. PubMed ID: 6423280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The enzymic defects in Morquio and Maroteaux-Lamy syndrome.
    Dorfman A; Arbogast B; Matalon R
    Adv Exp Med Biol; 1976; 68():261-76. PubMed ID: 820169
    [No Abstract]   [Full Text] [Related]  

  • 34. Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties.
    Freeman C; Hopwood JJ
    Biochem J; 1986 Feb; 234(1):83-92. PubMed ID: 3707548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.
    Wicker G; Prill V; Brooks D; Gibson G; Hopwood J; von Figura K; Peters C
    J Biol Chem; 1991 Nov; 266(32):21386-91. PubMed ID: 1718978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Maroteaux-Lamy syndrome: a case report].
    Mtar A; Charfeddine B; Braham I; Ben Abdallah J; Neffati S; Smach MA; Bourfifa Z; Ksouri M; Dridi H; Limem K
    Ann Biol Clin (Paris); 2011; 69(6):693-7. PubMed ID: 22123570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential degradation of a chondroitin sulphate trisaccharide by lysosomal enzymes from embryonic-chick epiphysial cartilage.
    Ingmar B; Wasteson A
    Biochem J; 1979 Apr; 179(1):7-13. PubMed ID: 475761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.
    Freeman C; Hopwood JJ
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):605-14. PubMed ID: 1546976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.
    Brooks DA; McCourt PA; Gibson GJ; Ashton LJ; Shutter M; Hopwood JJ
    Am J Hum Genet; 1991 Apr; 48(4):710-9. PubMed ID: 1901688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
    Duffey TA; Sadilek M; Scott CR; Turecek F; Gelb MH
    Anal Chem; 2010 Nov; 82(22):9587-91. PubMed ID: 20961069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.